B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NOS1

MOLECULAR TARGET

nitric oxide synthase 1

UniProt: P29475NCBI Gene: 484218 compounds

NOS1 (nitric oxide synthase 1) is targeted by 18 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NOS1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1tilarginine4.73112
2pimagedine4.5392
3l name3.7642
4l nil3.3728
5chlorzoxazone3.3026
61400w3.3026
77 nitroindazole2.9418
8Nitroarginine2.8316
92 aminopyridine2.8316
10l nio2.208
11gw 2741501.956
12thiocitrulline1.956
13ethylisothiourea1.795
14NG-Nitroarginine Methyl Ester1.614
15Arginine1.102
16Arginine1.102
17Guanethidine0.691
18bdb chembl18251680.691

About NOS1 as a Drug Target

NOS1 (nitric oxide synthase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 18 compounds with documented NOS1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NOS1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.